GB1107
CAS: 1978336-61-6
Ref. 3D-DED33661
| 5mg | 406.00 € | ||
| 10mg | 579.00 € | ||
| 25mg | 1,033.00 € | ||
| 50mg | 1,556.00 € | ||
| 100mg | 2,490.00 € |
Product Information
GB1107 is a small molecule that inhibits hepatic lipase, an enzyme that breaks down triglycerides in the liver. Inhibition of this enzyme leads to decreased lipolysis and reduced hepatic triglyceride content. GB1107 has been shown to reduce blood glucose levels in diabetic mice. This effect was due to inhibition of hepatic lipase, which resulted in reduced levels of free fatty acids. GB1107 also showed antitumor response by inducing apoptosis and cell cycle arrest in tumor cells. GB1107 was shown to have a logarithmic growth phase and induced epidermal growth factor (EGF) production in human liver cells. It also inhibited EGF-induced proliferation of human lung cancer cells, suggesting that it may be a potential biomarker for cancer diagnosis and treatment.
Chemical properties
Technical inquiry about: 3D-DED33661 GB1107
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
